BMO Capital Markets (:) has been given an average recommendation of “N/A” by the zero ratings firms that are presently covering the firm, MarketBeat reports.
TRADEMARK VIOLATION NOTICE: “BMO Capital Markets () Given Average Recommendation of “” by Brokerages” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/07/19/0-19-eps-expected-for-ritter-pharmaceuticals-inc-rttr-this-quarter-updated.html.
About BMO Capital Markets
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
Receive News & Ratings for BMO Capital Markets Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BMO Capital Markets and related companies with MarketBeat.com’s FREE daily email newsletter.